Teva Drug Cuts Disability in Parkinson's - Study

LONDON (Reuters) - Teva Pharmaceutical Industries Ltd's drug Azilect reduces disability in patients with advanced Parkinson's disease, according to new research published on Friday.

Continue to Teva Drug Cuts Disability in Parkinson's - Study on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz